KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synopsys (SNPS) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Synopsys (SNPS) over the last 16 years, with Jul 2025 value amounting to $2.6 billion.

  • Synopsys' Cash & Equivalents rose 40.81% to $2.6 billion in Q3 2025 from the same period last year, while for Jul 2025 it was $2.6 billion, marking a year-over-year increase of 40.81%. This contributed to the annual value of $4.1 billion for FY2024, which is 155.45% up from last year.
  • As of Q3 2025, Synopsys' Cash & Equivalents stood at $2.6 billion, which was down 81.82% from $14.3 billion recorded in Q2 2025.
  • In the past 5 years, Synopsys' Cash & Equivalents registered a high of $14.3 billion during Q2 2025, and its lowest value of $1.0 billion during Q1 2021.
  • For the 3-year period, Synopsys' Cash & Equivalents averaged around $3.2 billion, with its median value being $1.7 billion (2023).
  • As far as peak fluctuations go, Synopsys' Cash & Equivalents fell by 3.55% in 2024, and later spiked by 847.64% in 2025.
  • Over the past 5 years, Synopsys' Cash & Equivalents (Quarterly) stood at $1.4 billion in 2021, then declined by 1.07% to $1.4 billion in 2022, then rose by 11.67% to $1.6 billion in 2023, then spiked by 155.45% to $4.1 billion in 2024, then spiked by 40.81% to $2.6 billion in 2025.
  • Its Cash & Equivalents was $2.6 billion in Q3 2025, compared to $14.3 billion in Q2 2025 and $3.8 billion in Q1 2025.